Price
No data yet.
Social Signal Score
Analyst Ratings
33 analystsRevenue
$838.50M+112.87%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Frank H. Laukien
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 11,085
- Beta
- 1.22
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 2.73
Financials
Revenue
$838.50M+112.9%Net Income
$-52.00M-211.8%EBITDA
$17.30M-71.2%Free Cash Flow
$-106.20M-491.9%EPS (diluted)
$-0.41-241.4%Shares Outstanding (diluted)
152.20M-5.8%Operating Expenses
$333.20MCash & Debt
$184.90MReturn of Capital
$18.50MRevenue by Segment (annual)
$3.44BDividend per Share
$0.05Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.44B | $-8.60M | $-0.15 |
| 2024 | $3.37B | $113.10M | $0.76 |
| 2023 | $2.96B | $427.20M | $2.92 |
| 2022 | $2.53B | $296.60M | $2.00 |
| 2021 | $2.42B | $277.10M | $1.83 |
| 2020 | $1.99B | $157.80M | $1.03 |
| 2019 | $2.07B | $197.20M | $1.27 |
| 2018 | $1.90B | $179.70M | $1.15 |
| 2017 | $1.77B | $78.60M | $0.50 |
| 2016 | $1.61B | $153.60M | $0.95 |
| 2015 | $1.62B | $101.60M | $0.60 |
| 2014 | $1.81B | $56.70M | $0.34 |
| 2013 | $1.84B | $80.10M | $0.48 |
| 2012 | $1.79B | $77.50M | $0.47 |
Valuation
BRKRhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
118+17.53%Social Signal Score
Mentions (3)
- News (Marketaux)gurufocus.com·7d ago·Positive
J.P. Morgan Downgrades Bruker Corporation (BRKR) to Neutral Amid Revenue Growth Concerns Morgan downgraded Bruker Co[+326 characters]
View source ↗ - News (RSS)investing·21d ago·Neutral
Bruker Corporation stock hits 52-week high at 65.48 USD
View source ↗ - News (RSS)yahoo·45d ago·Neutral
Bruker (BRKR) Wagers On Fusion Energy While Wall Street Waits
View source ↗
Earnings
Mon, Nov 2(in 11 days)
Consensus estimate $0.42 per share
Typical surprise +2.2% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$0.49 vs $0.38beat
- Wed, May 6$0.31 vs $0.23beat
- Thu, Feb 12$0.59 vs $0.65miss
- Mon, Nov 3$0.60 vs $0.33beat
- Mon, Aug 4$0.32 vs $0.33miss
- Wed, May 7$0.47 vs $0.46beat
Estimates and results for BRKR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BRKR officers and directors.
- Bought
- —
- Sold
- $3.7m
0 trades
17 trades
- Munch Marksold
- Pusch Wolfgangsold
- Munch Marksold
- Munch Marksold
- Munch Marksold
- Munch Marksold
- Munch Marksold
- Munch Marksold
83 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Jun 12, 2023 (20d later)Sell$1,001 - $15,000
- Thomas Richard Carpersenate · DE · disclosed May 1, 2023 (14d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 10, 2022 (31d later)Buy$1,001 - $15,000
- Thomas Richard Carpersenate · DE · disclosed May 17, 2021 (178d later)Buy$1,001 - $15,000
- Bob Gibbshouse · OH07 · disclosed Dec 24, 2020 (27d later)Sell$1,001 - $15,000
- Thomas Richard Carpersenate · DE · disclosed Dec 2, 2020 (12d later)Buy$1,001 - $15,000
- Donna Shalalahouse · FL27 · disclosed Apr 27, 2020 (308d later)Sell$1,001 - $15,000
- Bob Gibbshouse · OH07 · disclosed Nov 26, 2019 (12d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.